CFDE Data Portal | Search PPIAP46

	Label	Description
	PPIAP46 Gene (Entity type)	ENSG00000260266 - peptidylprolyl isomerase A pseudogene 46
	GSE146358 dopamine 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213845 EZH2 inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 11 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE120214 GSE133308 TBXT brachyury inhibition 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 12 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 cisplatin 3 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

PPIAP46

ENSG00000260266 - peptidylprolyl isomerase A pseudogene 46

GSE146358 dopamine 5 v 2 human up

A Gene Set from LINCS

GSE213845 EZH2 inhibition 2 v 0 human up

A Gene Set from LINCS

GSE213845 EZH2 inhibition 4 v 0 human dn

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 4 v 3 human up

A Gene Set from LINCS

GSE143782 calcitriol 6 v 5 human up

A Gene Set from LINCS

GSE216043 cisplatin 11 v 4 human dn

A Gene Set from LINCS

GSE120214 GSE133308 TBXT brachyury inhibition 0 v 4 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 12 v 1 human dn

A Gene Set from LINCS

GSE216043 cisplatin 3 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.